No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue

ISSN:
1432-0428
Keywords:
Keywords Microdialysis ; obesity ; NIDDM ; beta-adrenergic receptor subtypes ; Pima Indians.
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Summary A Trp64Arg variant in the human β 3-adrenoceptor is associated with earlier onset of non-insulin-dependent diabetes mellitus and obesity in several populations. The present study investigated in vivo lipolysis in individuals homozygous for the ’variant' allele coding for arginine (Arg) in position 64 of the β 3-adrenoceptor or homozygous for the ’wild type' tryptophan (Trp) allele. Subjects were 25 healthy, non-diabetic Pima Indians, 8 Arg (2 males, 6 females; aged 34 ± 9 years, BMI 36.2 ± 7.7 kg/m2, 43 ± 11 % body fat [mean ± SD]), and 17 Trp (9 males, 8 females; aged 30 ± 5 years, BMI 30.4 ± 6.1 kg/m2, 39 ± 9 % body fat). After an overnight fast, a microdialysis probe was inserted in the subcutaneous adipose tissue and perfused with Ringer's solution. Dialysate was collected in 10-min fractions during a 30-min baseline and during 40 min with isoproterenol, a non-selective β-adrenergic agonist, added to the perfusate (1 μmol/l). Changes in rate of lipolysis were assessed as changes in dialysate glycerol concentration. The relative changes in dialysate glycerol concentrations in response to isoproterenol, expressed as percent over baseline, were similar in the two groups (i. e. 63 ± 30 and 74 ± 28 % in the Arg and Trp subjects, respectively). The results were also similar in the two groups after adjustment for sex and percentage of body fat. No differential effect of isoproterenol on blood flow was demonstrated between the two groups (assessed by the ethanol dilution technique). These results are consistent with in vitro studies showing no functional effect of the β 3-adrenoceptor variant, and/or indicate that the β 3-adrenoceptor is not very important for subcutaneous adipose tissue lipolysis. [Diabetalogia (1997) 40: 838–842]
Type of Medium:
Electronic Resource
URL:
_version_ 1798295381737472000
autor Snitker, S.
Odeleye, O. E.
Hellmér, J.
Boschmann, M.
Monroe, M. B.
Shuldiner, A. R.
Ravussin, E.
autorsonst Snitker, S.
Odeleye, O. E.
Hellmér, J.
Boschmann, M.
Monroe, M. B.
Shuldiner, A. R.
Ravussin, E.
book_url http://dx.doi.org/10.1007/s001250050757
datenlieferant nat_lic_papers
hauptsatz hsatz_simple
identnr NLM199941874
issn 1432-0428
journal_name Diabetologia
materialart 1
notes Summary A Trp64Arg variant in the human β 3-adrenoceptor is associated with earlier onset of non-insulin-dependent diabetes mellitus and obesity in several populations. The present study investigated in vivo lipolysis in individuals homozygous for the ’variant' allele coding for arginine (Arg) in position 64 of the β 3-adrenoceptor or homozygous for the ’wild type' tryptophan (Trp) allele. Subjects were 25 healthy, non-diabetic Pima Indians, 8 Arg (2 males, 6 females; aged 34 ± 9 years, BMI 36.2 ± 7.7 kg/m2, 43 ± 11 % body fat [mean ± SD]), and 17 Trp (9 males, 8 females; aged 30 ± 5 years, BMI 30.4 ± 6.1 kg/m2, 39 ± 9 % body fat). After an overnight fast, a microdialysis probe was inserted in the subcutaneous adipose tissue and perfused with Ringer's solution. Dialysate was collected in 10-min fractions during a 30-min baseline and during 40 min with isoproterenol, a non-selective β-adrenergic agonist, added to the perfusate (1 μmol/l). Changes in rate of lipolysis were assessed as changes in dialysate glycerol concentration. The relative changes in dialysate glycerol concentrations in response to isoproterenol, expressed as percent over baseline, were similar in the two groups (i. e. 63 ± 30 and 74 ± 28 % in the Arg and Trp subjects, respectively). The results were also similar in the two groups after adjustment for sex and percentage of body fat. No differential effect of isoproterenol on blood flow was demonstrated between the two groups (assessed by the ethanol dilution technique). These results are consistent with in vitro studies showing no functional effect of the β 3-adrenoceptor variant, and/or indicate that the β 3-adrenoceptor is not very important for subcutaneous adipose tissue lipolysis. [Diabetalogia (1997) 40: 838–842]
package_name Springer
publikationsjahr_anzeige 1997
publikationsjahr_facette 1997
publikationsjahr_intervall 8004:1995-1999
publikationsjahr_sort 1997
publisher Springer
reference 40 (1997), S. 838-842
schlagwort Keywords Microdialysis
obesity
NIDDM
beta-adrenergic receptor subtypes
Pima Indians.
search_space articles
shingle_author_1 Snitker, S.
Odeleye, O. E.
Hellmér, J.
Boschmann, M.
Monroe, M. B.
Shuldiner, A. R.
Ravussin, E.
shingle_author_2 Snitker, S.
Odeleye, O. E.
Hellmér, J.
Boschmann, M.
Monroe, M. B.
Shuldiner, A. R.
Ravussin, E.
shingle_author_3 Snitker, S.
Odeleye, O. E.
Hellmér, J.
Boschmann, M.
Monroe, M. B.
Shuldiner, A. R.
Ravussin, E.
shingle_author_4 Snitker, S.
Odeleye, O. E.
Hellmér, J.
Boschmann, M.
Monroe, M. B.
Shuldiner, A. R.
Ravussin, E.
shingle_catch_all_1 Snitker, S.
Odeleye, O. E.
Hellmér, J.
Boschmann, M.
Monroe, M. B.
Shuldiner, A. R.
Ravussin, E.
No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
Keywords Microdialysis
obesity
NIDDM
beta-adrenergic receptor subtypes
Pima Indians.
Keywords Microdialysis
obesity
NIDDM
beta-adrenergic receptor subtypes
Pima Indians.
Summary A Trp64Arg variant in the human β 3-adrenoceptor is associated with earlier onset of non-insulin-dependent diabetes mellitus and obesity in several populations. The present study investigated in vivo lipolysis in individuals homozygous for the ’variant' allele coding for arginine (Arg) in position 64 of the β 3-adrenoceptor or homozygous for the ’wild type' tryptophan (Trp) allele. Subjects were 25 healthy, non-diabetic Pima Indians, 8 Arg (2 males, 6 females; aged 34 ± 9 years, BMI 36.2 ± 7.7 kg/m2, 43 ± 11 % body fat [mean ± SD]), and 17 Trp (9 males, 8 females; aged 30 ± 5 years, BMI 30.4 ± 6.1 kg/m2, 39 ± 9 % body fat). After an overnight fast, a microdialysis probe was inserted in the subcutaneous adipose tissue and perfused with Ringer's solution. Dialysate was collected in 10-min fractions during a 30-min baseline and during 40 min with isoproterenol, a non-selective β-adrenergic agonist, added to the perfusate (1 μmol/l). Changes in rate of lipolysis were assessed as changes in dialysate glycerol concentration. The relative changes in dialysate glycerol concentrations in response to isoproterenol, expressed as percent over baseline, were similar in the two groups (i. e. 63 ± 30 and 74 ± 28 % in the Arg and Trp subjects, respectively). The results were also similar in the two groups after adjustment for sex and percentage of body fat. No differential effect of isoproterenol on blood flow was demonstrated between the two groups (assessed by the ethanol dilution technique). These results are consistent with in vitro studies showing no functional effect of the β 3-adrenoceptor variant, and/or indicate that the β 3-adrenoceptor is not very important for subcutaneous adipose tissue lipolysis. [Diabetalogia (1997) 40: 838–842]
1432-0428
14320428
Springer
shingle_catch_all_2 Snitker, S.
Odeleye, O. E.
Hellmér, J.
Boschmann, M.
Monroe, M. B.
Shuldiner, A. R.
Ravussin, E.
No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
Keywords Microdialysis
obesity
NIDDM
beta-adrenergic receptor subtypes
Pima Indians.
Keywords Microdialysis
obesity
NIDDM
beta-adrenergic receptor subtypes
Pima Indians.
Summary A Trp64Arg variant in the human β 3-adrenoceptor is associated with earlier onset of non-insulin-dependent diabetes mellitus and obesity in several populations. The present study investigated in vivo lipolysis in individuals homozygous for the ’variant' allele coding for arginine (Arg) in position 64 of the β 3-adrenoceptor or homozygous for the ’wild type' tryptophan (Trp) allele. Subjects were 25 healthy, non-diabetic Pima Indians, 8 Arg (2 males, 6 females; aged 34 ± 9 years, BMI 36.2 ± 7.7 kg/m2, 43 ± 11 % body fat [mean ± SD]), and 17 Trp (9 males, 8 females; aged 30 ± 5 years, BMI 30.4 ± 6.1 kg/m2, 39 ± 9 % body fat). After an overnight fast, a microdialysis probe was inserted in the subcutaneous adipose tissue and perfused with Ringer's solution. Dialysate was collected in 10-min fractions during a 30-min baseline and during 40 min with isoproterenol, a non-selective β-adrenergic agonist, added to the perfusate (1 μmol/l). Changes in rate of lipolysis were assessed as changes in dialysate glycerol concentration. The relative changes in dialysate glycerol concentrations in response to isoproterenol, expressed as percent over baseline, were similar in the two groups (i. e. 63 ± 30 and 74 ± 28 % in the Arg and Trp subjects, respectively). The results were also similar in the two groups after adjustment for sex and percentage of body fat. No differential effect of isoproterenol on blood flow was demonstrated between the two groups (assessed by the ethanol dilution technique). These results are consistent with in vitro studies showing no functional effect of the β 3-adrenoceptor variant, and/or indicate that the β 3-adrenoceptor is not very important for subcutaneous adipose tissue lipolysis. [Diabetalogia (1997) 40: 838–842]
1432-0428
14320428
Springer
shingle_catch_all_3 Snitker, S.
Odeleye, O. E.
Hellmér, J.
Boschmann, M.
Monroe, M. B.
Shuldiner, A. R.
Ravussin, E.
No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
Keywords Microdialysis
obesity
NIDDM
beta-adrenergic receptor subtypes
Pima Indians.
Keywords Microdialysis
obesity
NIDDM
beta-adrenergic receptor subtypes
Pima Indians.
Summary A Trp64Arg variant in the human β 3-adrenoceptor is associated with earlier onset of non-insulin-dependent diabetes mellitus and obesity in several populations. The present study investigated in vivo lipolysis in individuals homozygous for the ’variant' allele coding for arginine (Arg) in position 64 of the β 3-adrenoceptor or homozygous for the ’wild type' tryptophan (Trp) allele. Subjects were 25 healthy, non-diabetic Pima Indians, 8 Arg (2 males, 6 females; aged 34 ± 9 years, BMI 36.2 ± 7.7 kg/m2, 43 ± 11 % body fat [mean ± SD]), and 17 Trp (9 males, 8 females; aged 30 ± 5 years, BMI 30.4 ± 6.1 kg/m2, 39 ± 9 % body fat). After an overnight fast, a microdialysis probe was inserted in the subcutaneous adipose tissue and perfused with Ringer's solution. Dialysate was collected in 10-min fractions during a 30-min baseline and during 40 min with isoproterenol, a non-selective β-adrenergic agonist, added to the perfusate (1 μmol/l). Changes in rate of lipolysis were assessed as changes in dialysate glycerol concentration. The relative changes in dialysate glycerol concentrations in response to isoproterenol, expressed as percent over baseline, were similar in the two groups (i. e. 63 ± 30 and 74 ± 28 % in the Arg and Trp subjects, respectively). The results were also similar in the two groups after adjustment for sex and percentage of body fat. No differential effect of isoproterenol on blood flow was demonstrated between the two groups (assessed by the ethanol dilution technique). These results are consistent with in vitro studies showing no functional effect of the β 3-adrenoceptor variant, and/or indicate that the β 3-adrenoceptor is not very important for subcutaneous adipose tissue lipolysis. [Diabetalogia (1997) 40: 838–842]
1432-0428
14320428
Springer
shingle_catch_all_4 Snitker, S.
Odeleye, O. E.
Hellmér, J.
Boschmann, M.
Monroe, M. B.
Shuldiner, A. R.
Ravussin, E.
No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
Keywords Microdialysis
obesity
NIDDM
beta-adrenergic receptor subtypes
Pima Indians.
Keywords Microdialysis
obesity
NIDDM
beta-adrenergic receptor subtypes
Pima Indians.
Summary A Trp64Arg variant in the human β 3-adrenoceptor is associated with earlier onset of non-insulin-dependent diabetes mellitus and obesity in several populations. The present study investigated in vivo lipolysis in individuals homozygous for the ’variant' allele coding for arginine (Arg) in position 64 of the β 3-adrenoceptor or homozygous for the ’wild type' tryptophan (Trp) allele. Subjects were 25 healthy, non-diabetic Pima Indians, 8 Arg (2 males, 6 females; aged 34 ± 9 years, BMI 36.2 ± 7.7 kg/m2, 43 ± 11 % body fat [mean ± SD]), and 17 Trp (9 males, 8 females; aged 30 ± 5 years, BMI 30.4 ± 6.1 kg/m2, 39 ± 9 % body fat). After an overnight fast, a microdialysis probe was inserted in the subcutaneous adipose tissue and perfused with Ringer's solution. Dialysate was collected in 10-min fractions during a 30-min baseline and during 40 min with isoproterenol, a non-selective β-adrenergic agonist, added to the perfusate (1 μmol/l). Changes in rate of lipolysis were assessed as changes in dialysate glycerol concentration. The relative changes in dialysate glycerol concentrations in response to isoproterenol, expressed as percent over baseline, were similar in the two groups (i. e. 63 ± 30 and 74 ± 28 % in the Arg and Trp subjects, respectively). The results were also similar in the two groups after adjustment for sex and percentage of body fat. No differential effect of isoproterenol on blood flow was demonstrated between the two groups (assessed by the ethanol dilution technique). These results are consistent with in vitro studies showing no functional effect of the β 3-adrenoceptor variant, and/or indicate that the β 3-adrenoceptor is not very important for subcutaneous adipose tissue lipolysis. [Diabetalogia (1997) 40: 838–842]
1432-0428
14320428
Springer
shingle_title_1 No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
shingle_title_2 No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
shingle_title_3 No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
shingle_title_4 No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
sigel_instance_filter dkfz
geomar
wilbert
ipn
albert
fhp
source_archive Springer Online Journal Archives 1860-2000
timestamp 2024-05-06T09:35:17.894Z
titel No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
titel_suche No effect of the Trp64Arg β3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue
topic WW-YZ
uid nat_lic_papers_NLM199941874